Risk factor profile and pregnancy outcome in women with type 1 and type 2 diabetes mellitus

Journal of Women's Health

Volumn 20, Issue 2, 2011, Pages 263-271

  Handisurya, Ammon ^a   Bancher Todesca, Dagmar ^b   Schober, Edith ^a   Klein, Katharina ^b   Tobler, Karin ^a   Schneider, Barbara ^a   Pollak, Arnold ^a   Husslein, Peter ^b   Luger, Anton ^a   Kautzky Willer, Alexandra ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; BLOOD GLUCOSE MONITORING; BODY MASS; CONFERENCE PAPER; CONGENITAL MALFORMATION; EMBRYO DEATH; FEMALE; HUMAN; INFANT MORTALITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PERINATAL DEATH; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AUSTRIA; COMORBIDITY; CONGENITAL ABNORMALITIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PRENATAL CARE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 79951753013     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2010.2033     Document Type: Conference Paper

References (44)

1. Workshop Report. Diabetes care and research in Europe: The Saint Vincent Declaration. Diabetes Med 1990;7:360.
2. Confidential Enquiry into Maternal and Child Health. Pregnancy in women with type 1 and type 2 diabetes in 2002-03, England, Wales and Northern Ireland. London: CEMACH, 2005.
3. Diabetes and Pregnancy Group, France. French multicentric survey of outcomes of pregnancy in women with pregestational diabetes. Diabetes Care 2003;26:2990-2993.
4. Clausen TD, Mathiesen E, Ekbom P, Hellmuth E, Mandrup- Poulsen T, Damm P. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 2005;28:323-328. (Pubitemid 40170934)
5. Nielsen GL, Moller M, Sorensen HT. HbA1c in early diabetic pregnancy and pregnancy outcomes. Diabetes Care 2006;29:2612-2616.
6. Dabalea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity. A study of discordant sibships. Diabetes Care 2000;49:2208-2211.
7. Feig DS, Palda VA. Type 2 diabetes in pregnancy: A growing concern. Lancet 2002;359:1690-1692. (Pubitemid 34518536)
8. Cundy T, Gamble G, Neale L, et al. Differing causes of pregnancy loss in type 1 and type 2 diabetes. Diabetes Care 2007;30:2603-2607. (Pubitemid 47547804)
9. Farrell T, Neale L, Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabetes Med 2002;19:322-326. (Pubitemid 34592159)
10. Cundy T, Gamble G, Townend K, Henley PG, MacPherson P, Roberts AB. Perinatal mortality in type 2 diabetes mellitus. Diabetes Med 2000;17:33-39. (Pubitemid 30094178)
11. Omori Y, Jovanovic L. Proposal for the reconsideration of the definition of gestational diabetes. Diabetes Care 2005;28:2592-2593. (Pubitemid 41384326)
12. Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisting diabetes for pregnancy: Summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060-1079.
13. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetriciansgynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 2001;98:525-538.
14. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29 (Suppl 1):S43-48.
16. European Registration of Congenital Anomalies. EUROCAT Report 8: Surveillance of congenital anomalies in Europe 1980-1999. Belfast: University of Ulster, 2002.
17. World Health Organization. Recommended definitions, terminology and format for statistical tables related to the perinatal period. Acta Obstet Gynecol Scand 1977;56:247-253.
18. Regan L, Rai R. Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:839-854.
19. Wyatt PR, Owolabi T, Meier C, Huang T. Age-specific risk of fetal loss observed in a second trimester serum screening population. Am J Obstet Gynecol 2005;192:240-246. (Pubitemid 40164248)
20. Ang C, Lumsden MA. Diabetes and the maternal resistance vasculature. Clin Sci 2001;101:719-729. (Pubitemid 33135356)
21. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonist during pregnancy and the risk of birth defects. N Engl J Med 2000;343:1608-1614. (Pubitemid 32162984)
22. George L, Mills JL, Johansson AL, et al. Plasma folate levels and risk of spontaneous abortion. JAMA 2002;288:1867-1873. (Pubitemid 35168142)
23. Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can 2006;28:680-689.
24. Malik S, Cleves MA, Honein MA, et al. National Birth Defects Prevention Study. Maternal smoking and congenital heart defects. Pediatrics 2008;121:e810-816.
25. Hughes RCE, Rowan JA. Pregnancy in women with type 2 diabetes: Who takes metformin and what is the outcome? Diabet Med 2006;23:318-322.
26. Gilbert C, Valois M, Koren G. Pregnancy outcome after firsttrimester exposure to metformin: A meta-analysis. Fertil Steril 2006;86:658-663. (Pubitemid 44307028)
27. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP, MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008;358:2003-2015. (Pubitemid 351656455)
28. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-1138.
29. Ekpebegh CO, Coetzee EJ, van der Merwe L, Levitt NS. A 10-year retrospective analysis of pregnancy outcome in pregestational type 2 diabetes: Comparison of insulin and oral glucose-lowering agents. Diabetes Med 2007;24:253-258.
30. Piacquadio K, Hollingsworth R, Murphy H. Effects of inutero exposure to oral hypoglycaemic drugs. Lancet 1991;338:866-869.
31. Hellmuth E, Damm P, Mølsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabetes Med 2000;17: 507-511. (Pubitemid 30660151)
32. Vangen S, Stoltenberg C, Holan S, et al. Outcome of pregnancy among immigrant women with diabetes. Diabetes Care 2003;26:327-332. (Pubitemid 36929050)
33. Huang L, Sauve R, Birkett N, Fergusson D, van Walraven C. Maternal age and risk of stillbirth: A systemic review. Can Med Assoc J 2008;178:165-172.
34. Kristensen J, Vestergaard M, Wisborg K, Kesmodel U, Secher NJ. Prepregnancy weight and the risk of stillbirth and neonatal death. Br J Obstet Gynecol 2006;112:403-408.
35. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197.
36. Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R. Gestational diabetes mellitus diagnosed during early pregnancy. Am J Obstet Gynecol 2000;182:346-350. (Pubitemid 30127346)
37. Schaefer UM, Songster G, Xiang A, Berkowitz K, Buchanan TA, Kjos SL. Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am J Obstet Gynecol 1997;177:1165-1171. (Pubitemid 27525377)
38. OSullivan JB. Gestational diabetes and its significance. In: Camerini-Davalos R, Cole HS, eds. Early diabetes. New York: Academic Press, 1970:339-344.
39. Evers IM, Ter Braak EWMT, De Valk HW, Van der Schoot B, Janssen N, Visser GHA. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. Diabetes Care 2002;25:554-559. (Pubitemid 41103352)
40. Lu GC, Rouse DJ, DuBard M, Cliver S, Kimberlin D, Hauth JC. The effect of the increasing prevalence of maternal obesity on perinatal morbidity. Am J Obstet Gynecol 2001;185:845-849. (Pubitemid 32980523)
41. Spanish Group for the Study of the Impact of Carpenter and Coustan GDM Thresholds. Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia. Diabetologia 2005;48:1736-1742.
42. Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 2004;191:964-968. (Pubitemid 39298142)
43. Gestation and Diabetes in France Study Group. Multicenter survey of diabetic pregnancy in France. Diabetes Care 1991;14:994-1000
44. Hadden DR, Stanisstreet M, Casson IF, et al. Obstetric and diabetic care for pregnancy in diabetic women: 10 years outcome analysis, 1985-1995. Diabetes Med 2001;18:546-553. (Pubitemid 32823077)